Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Uri Mbonye has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Jonathan Karn

    Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine

    12 shared publications
  • Konstantin Leskov

    Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA

    4 shared publications
  • Meenakshi Shukla

    Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, USA

    4 shared publications
  • Saba Valadkhan

    Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, USA

    3 shared publications
  • Giridharan Gokulrangan

    Center for Proteomics and Bioinformatics Case Western Reserve University School of Medicine Cleveland Ohio USA

    2 shared publications
  • Mark R. Chance

    Center for Proteomics and Bioinformatics Case Western Reserve University School of Medicine Cleveland Ohio USA

    2 shared publications

Latest Publications

  • Open Access

    HIV-1 Tat Forms a Dissociable Complex with 7SK snRNP and Exhibits Clade Differences in Reversing the Sequestration of P-TEFb

    by Amie Donner, Taebin Son, Sanjna Boda, Claire T. Kenney, Alexis Chiandussi, Rania Rodríguez, Jonathan Karn, Uri Mbonye

    Recent efforts to employ ectopic Tat as a latency-reversal strategy can benefit from the identification of Tat variants with more efficient transactivation activity. Tat primarily serves as a recruiter of the host transcription elongation factor P-TEFb to proviral HIV to stimulate transcription elongation. Tat can also functionally interact with a host of chromatin-modifying enzymes to promote HIV transcription initiation. In actively dividing T cells, P-TEFb is kept inactive by the 7SK snRNP complex. Although Tat is capable of physically extracting P-TEFb from 7SK snRNP as well as forming an assembly with the sequestrator complex, it is unclear whether Tat:7SK snRNP (Tat:7SK) is a reversible functional intermediate that mediates the recruitment of P-TEFb to proviral HIV. This study explored the reversibility of Tat:7SK and whether Tat clade variants differ in their ability to assemble this complex, mobilize P-TEFb and transactivate latent HIV. While the ectopic expression of clade B NL4-3 Tat caused a substantial dissociation of P-TEFb from 7SK snRNP, affinity tag-based immunoprecipitation experiments confirmed the assembly of Tat:7SK with the displacement of the P-TEFb inhibitory component HEXIM1. The P-TEFb kinase inhibitor flavopiridol (FVP), known to rapidly dissociate P-TEFb from 7SK snRNP, also induced the efficient release of Tat:P-TEFb from Tat:7SK, suggesting that P-TEFb remains a component of this latter complex. While Tat variants representing clades A, B, C and CRF_AE exhibited comparable binding to P-TEFb, clade D Tat showed the least binding. Unlike clades B and CRF_AE, clades A and C Tat associated much more weakly with the core 7SK snRNP subunits MEPCE and LARP7, indicating that their bound P-TEFb is likely liberated. Evaluation of latent HIV reactivation in the Jurkat 2D10 clonal model revealed a rapid loss of Tat transactivation capacity over time across all clades examined, with the most striking disparity observed between Clades A and D. Overall, our findings reveal substantial clade-specific differences in Tat’s ability to liberate P-TEFb from 7SK snRNP and transactivate latent HIV, with the clade A variant displaying the highest potency. Contrary to the prevailing paradigm that Tat:7SK is a “dead-end” complex that is unable to avail P-TEFb for transcriptional control, we show that it is a reversible intermediate from which Tat:P-TEFb can be released en bloc.

  • Open Access

    RasGRP1 agonists stimulate P-TEFb biogenesis via MEK-ERK-mTORC1 signaling to reverse HIV latency with minimal CD4 downregulation

    by Uri Mbonye, Ana Bellomo, Eleonora Elhalem, Lucia Gandolfi Donadio, Muda Yang, Amie Donner, Maria Julieta Comin, Jonathan Karn

    Reactivation of latent HIV to facilitate clearance of persisting infected cells requires identifying non-toxic latency-reversing agents (LRAs) that activate P-TEFb, a cellular transcription factor essential for efficient HIV RNA synthesis. Diacylglycerol (DAG)-mimicking PKC agonists induce P-TEFb to reverse HIV latency mainly through a PKC-independent RasGRP1-Ras-Raf-MEK-ERK1/2 pathway, but also elicit global T-cell activation and a drastic downregulation of CD4 receptors. Here, we demonstrate that synthetic DAG-indololactones, which preferentially bind RasGRP1 over PKC by up to 60-fold, strongly induce posttranscriptional P-TEFb expression in memory CD4+ T cells via MEK-ERK1/2-mTORC1 signaling without triggering T-cell activation markers and with minimal CD4 loss. Elevation of T-cell activation markers by natural and synthetic PKC agonists proceeds through MEK-ERK1/2 but is independent of mTORC1 activity. Combinations of the DAG-indololactone 2A127 and HDAC inhibitors synergistically reactivate latent HIV in a primary T-cell model and CD4+ T cells from treated individuals. These findings suggest that a combination LRA approach targeting P-TEFb production through RasGRP1-ERK1/2-mTORC1 signaling and the epigenetic activation of proviral HIV can efficiently and safely reverse HIV latency.

  • Open Access

    HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency

    by Leah M. Plasek Hegde, Lalith S. Gunawardane, Farshad Niazi, Uri Mbonye, Konstantin Leskov, Gani Perez, Curtis Dobrowolski, Meenakshi Shukla, William S. Nutt, Jonathan Karn, et al.

    Human immunodeficiency virus (HIV) persists in infected individuals despite effective antiretroviral therapy due to the rapid establishment of latent reservoirs, mainly composed of quiescent memory CD4+ T cells. The mechanisms governing latent reservoir formation remain poorly understood. Here, using single-cell RNA-seq and functional studies in human primary CD4+ T cell models, we show that HIV infection with reporter constructs and laboratory and patient-derived strains triggers transcriptomic remodelling, activating the p53 pathway and a quiescence programme mediated by Krüppel-like factor 2 (KLF2), a key quiescence regulator. Loss- and gain-of-function studies, including unbiased shRNA screens and confirmatory studies in CD4+ T cells from HIV+ donors, demonstrate that HIV infection drives KLF2 and p53 signalling, which downregulate MYC and proliferation pathways, resulting in proviral transcriptional silencing. This enhances latent reservoir formation in T cells, ensuring viral persistence. These findings present a mechanism for forming the latent HIV reservoir and broaden the repertoire of strategies through which viruses control host cells to their advantage.


  • Open Access

    Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation

    by Fredrick Kizito, Kien Nguyen, Uri Mbonye, Meenakshi Shukla, Benjamin Luttge, Mary Ann Checkley, Anna Agaponova, Konstantin Leskov, Jonathan Karn

    Using an immunofluorescence assay based on CRISPR-dCas9-gRNA complexes that selectively bind to the HIV LTR (HIV Cas-FISH), we traced changes in HIV DNA localization in primary effector T cells from early infection until the cells become quiescent as they transition to memory cells. Unintegrated HIV DNA colocalized with CPSF6 and HIV capsid (CA, p24) was found in the cytoplasm and nuclear periphery at days 1 and 3 post infection. From days 3 to 7, most HIV DNA was distributed primarily in the nuclear intermediate euchromatic compartment and was transcribed. By day 21, the cells had entered quiescence, and HIV DNA accumulated in the perinucleolar compartment (PNC). The localization of proviruses to the PNC was blocked by integrase inhibitor Raltegravir, suggesting it was due to chromosomal rearrangements. During the reactivation of latently infected cells through the T cell receptor (TCR), nascent viral mRNA transcripts associated with HIV DNA in the PNC were detected. The viral trans-activator Tat and its regulatory partners, P-TEFb and 7SK snRNA, assembled in large interchromatin granule clusters near the provirus within 2 h of TCR activation. As T cell activation progressed, the HIV DNA shifted away from the PNC. HIV DNA in latently infected memory T cells from patients also accumulated in the PNC and showed identical patterns of nuclear rearrangements after cellular reactivation. Thus, in contrast to transformed cells where proviruses are found primarily at the nuclear periphery, in primary memory T cells, the nuclear architecture undergoes rearrangements that shape the transcriptional silencing and reactivation of proviral HIV.


  • Top Cited Papers
    Open Access

    The cell biology of HIV-1 latency and rebound

    by Uri Mbonye, Jonathan Karn

    Transcriptionally latent forms of replication-competent proviruses, present primarily in a small subset of memory CD4+ T cells, pose the primary barrier to a cure for HIV-1 infection because they are the source of the viral rebound that almost inevitably follows the interruption of antiretroviral therapy. Over the last 30 years, many of the factors essential for initiating HIV-1 transcription have been identified in studies performed using transformed cell lines, such as the Jurkat T-cell model. However, as highlighted in this review, several poorly understood mechanisms still need to be elucidated, including the molecular basis for promoter-proximal pausing of the transcribing complex and the detailed mechanism of the delivery of P-TEFb from 7SK snRNP. Furthermore, the central paradox of HIV-1 transcription remains unsolved: how are the initial rounds of transcription achieved in the absence of Tat? A critical limitation of the transformed cell models is that they do not recapitulate the transitions between active effector cells and quiescent memory T cells. Therefore, investigation of the molecular mechanisms of HIV-1 latency reversal and LRA efficacy in a proper physiological context requires the utilization of primary cell models. Recent mechanistic studies of HIV-1 transcription using latently infected cells recovered from donors and ex vivo cellular models of viral latency have demonstrated that the primary blocks to HIV-1 transcription in memory CD4+ T cells are restrictive epigenetic features at the proviral promoter, the cytoplasmic sequestration of key transcription initiation factors such as NFAT and NF-κB, and the vanishingly low expression of the cellular transcription elongation factor P-TEFb. One of the foremost schemes to eliminate the residual reservoir is to deliberately reactivate latent HIV-1 proviruses to enable clearance of persisting latently infected cells—the “Shock and Kill” strategy. For “Shock and Kill” to become efficient, effective, non-toxic latency-reversing agents (LRAs) must be discovered. Since multiple restrictions limit viral reactivation in primary cells, understanding the T-cell signaling mechanisms that are essential for stimulating P-TEFb biogenesis, initiation factor activation, and reversing the proviral epigenetic restrictions have become a prerequisite for the development of more effective LRAs.


  • Open Access

    Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways

    by Uri Mbonye, Konstantin Leskov, Meenakshi Shukla, Saba Valadkhan, Jonathan Karn

    The switch between HIV latency and productive transcription is regulated by an auto-feedback mechanism initiated by the viral trans-activator Tat, which functions to recruit the host transcription elongation factor P-TEFb to proviral HIV. A heterodimeric complex of CDK9 and one of three cyclin T subunits, P-TEFb is expressed at vanishingly low levels in resting memory CD4+T cells and cellular mechanisms controlling its availability are central to regulation of the emergence of HIV from latency. Using a well-characterized primary T-cell model of HIV latency alongside healthy donor memory CD4+T cells, we characterized specific T-cell receptor (TCR) signaling pathways that regulate the generation of transcriptionally active P-TEFb, defined as the coordinate expression of cyclin T1 and phospho-Ser175 CDK9. Protein kinase C (PKC) agonists, such as ingenol and prostratin, stimulated active P-TEFb expression and reactivated latent HIV with minimal cytotoxicity, even in the absence of intracellular calcium mobilization with an ionophore. Unexpectedly, inhibition-based experiments demonstrated that PKC agonists and TCR-mobilized diacylglycerol signal through MAP kinases ERK1/2 rather than through PKC to effect the reactivation of both P-TEFb and latent HIV. Single-cell and bulk RNA-seq analyses revealed that of the four known isoforms of the Ras guanine nucleotide exchange factor RasGRP, RasGRP1 is by far the predominantly expressed diacylglycerol-dependent isoform in CD4+T cells. RasGRP1 should therefore mediate the activation of ERK1/2 via Ras-Raf signaling upon TCR co-stimulation or PKC agonist challenge. Combined inhibition of the PI3K-mTORC2-AKT-mTORC1 pathway and the ERK1/2 activator MEK prior to TCR co-stimulation abrogated active P-TEFb expression and substantially suppressed latent HIV reactivation. Therefore, contrary to prevailing models, the coordinate reactivation of P-TEFb and latent HIV in primary T cells following either TCR co-stimulation or PKC agonist challenge is independent of PKC but rather involves two complementary signaling arms of the TCR cascade, namely, RasGRP1-Ras-Raf-MEK-ERK1/2 and PI3K-mTORC2-AKT-mTORC1.


  • Open Access

    Biogenesis of P-TEFb in CD4 + T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways

    by Uri Mbonye, Konstantin Leskov, Meenakshi Shukla, Saba Valadkhan, Jonathan Karn

    The switch between HIV latency and productive transcription is regulated by an auto-feedback mechanism initiated by the viral trans-activator Tat, which functions to recruit the host transcription elongation factor P-TEFb to proviral HIV. A heterodimeric complex of CDK9 and one of three cyclin T subunits, P-TEFb is expressed at vanishingly low levels in resting memory CD4 + T cells and cellular mechanisms controlling its availability are central to regulation of the emergence of HIV from latency. Using a well-characterized primary T-cell model of HIV latency alongside healthy donor memory CD4 + T cells, we characterized specific T-cell receptor (TCR) signaling pathways that regulate the generation of transcriptionally active P-TEFb, defined as the coordinate expression of cyclin T1 and phospho-Ser175 CDK9. Protein kinase C (PKC) agonists, such as ingenol and prostratin, stimulated active P-TEFb expression and reactivated latent HIV with minimal cytotoxicity, even in the absence of intracellular calcium mobilization with an ionophore. Unexpectedly, inhibition-based experiments demonstrated that PKC agonists and TCR-mobilized diacylglycerol signal through MAP kinases ERK1/2 rather than through PKC to effect the reactivation of both P-TEFb and latent HIV. Single-cell and bulk RNA-seq analyses revealed that of the four known isoforms of the Ras guanine nucleotide exchange factor RasGRP, RasGRP1 is by far the predominantly expressed diacylglycerol-dependent isoform in CD4 + T cells. RasGRP1 should therefore mediate the activation of ERK1/2 via Ras-Raf signaling upon TCR co-stimulation or PKC agonist challenge. Combined inhibition of the PI3K-mTORC2-AKT-mTORC1 pathway and the ERK1/2 activator MEK prior to TCR co-stimulation abrogated active P-TEFb expression and substantially suppressed latent HIV reactivation. Therefore, contrary to prevailing models, the coordinate reactivation of P-TEFb and latent HIV in primary T cells following either TCR co-stimulation or PKC agonist challenge is independent of PKC but rather involves two complementary signaling arms of the TCR cascade, namely, RasGRP1-Ras-Raf-MEK-ERK1/2 and PI3K-mTORC2-AKT-mTORC1. Author Summary: Dissecting the cellular pathways through which HIV emerges from latency is a key step in the development of therapeutically viable approaches for latency reversal and eventual clearance of persistent HIV in infected individuals. The essential host transcription elongation factor P-TEFb, a heterodimer of CDK9 kinase and a regulatory cyclin T subunit, is a critical mediator of the trans-activation of latent HIV. Availability of P-TEFb for proviral transcription is highly limited due to a posttranscriptional restriction in cyclin T1 expression and dephosphorylation of CDK9 on its activation loop. Using a well-characterized primary T-cell model of HIV latency alongside healthy donor memory CD4 + T cells, we have now defined the signaling pathways that are essential for the generation of transcriptionally active P-TEFb and, consequently, proviral reactivation. Crucial among these findings is the demonstration that protein kinase C (PKC) agonists signal through off-target activation of RasGRP1-Ras-Raf-MEK-ERK1/2 to effect the reactivation of both P-TEFb and proviral HIV. Understanding these pathways should lead to the discovery of novel highly selective activators of P-TEFb to improve the efficiency of HIV reactivation in the memory T-cell population of virally suppressed individuals.


  • Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P‐TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression

    by Uri R. Mbonye, Benlian Wang, Giridharan Gokulrangan, Mark R. Chance, Jonathan Karn

    Efficient HIV transcription requires P‐TEFb, an essential co‐factor for Tat. In actively replicating cells, P‐TEFb is incorporated into the 7SK snRNP complex together with the repressor protein HEXIM1. Using an affinity purification‐tandem mass spectrometry approach to identify modification sites on HEXIM1 that regulate the sequestration of P‐TEFb by 7SK snRNP, we found that HEXIM1 can be phosphorylated on adjacent residues in a region immediately upstream of the coiled‐coil dimerization domain (Ser268, Thr270, Tyr271, and Tyr274). Phosphomimetic mutations of Tyr271 and Tyr274 disrupted the assembly of P‐TEFb and HEXIM1 into the 7SK snRNP complex. Although Y271E/Y274E did not adversely affect the nuclear localization pattern of HEXIM1, it induced the redistribution of the CDK9 subunit of P‐TEFb into the cytoplasm. By contrast, the Y271F/Y274F HEXIM1 mutant assembled normally with P‐TEFb within the 7SK snRNP complex but severely reduced proviral gene expression in T cells in response to activation signals and caused a severe growth defect of Jurkat T cells. Thus, Y271F/Y274F, which cannot be phosphorylated on these residues, appears to block the exchange of active P‐TEFb from the 7SK complex, thereby limiting the level of P‐TEFb below the threshold required to support transcription elongation of the HIV provirus and cellular genes.